Cite

    Kanagaratnam, P. et al. (2023). Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial. Europace. 25 (3), pp. 863-872. [Online].